Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) shares traded up 0.4% during trading on Thursday . The company traded as high as $5.4599 and last traded at $5.45. 198,556 shares traded hands during mid-day trading, a decline of 4% from the average session volume of 205,918 shares. The stock had previously closed at $5.43.
Health Sciences Acquisitions Co. 2 Price Performance
The firm has a 50-day moving average of $4.43 and a two-hundred day moving average of $4.28.
Health Sciences Acquisitions Co. 2 Company Profile
Health Sciences Acquisitions Co 2 is a Delaware‐incorporated special purpose acquisition company (SPAC) established to pursue a business combination with a company in the health sciences sector. Listed on the Nasdaq under the ticker HSAQ, the firm completed an initial public offering in early 2021, raising capital through the sale of units comprised of common stock and warrants.
As a blank‐check vehicle, Health Sciences Acquisitions Co 2 does not engage in commercial operations; rather, it focuses exclusively on identifying and combining with a private company operating in biotechnology, pharmaceuticals, medical devices or related life sciences fields.
Further Reading
- Five stocks we like better than Health Sciences Acquisitions Co. 2
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
